Location History:
- Tokushima, JP (1980 - 1993)
- Mishima, JP (1994 - 1998)
- Michima, JP (1998)
Company Filing History:
Years Active: 1980-1998
Title: Hiraki Ueda - A Pioneer in Antimicrobial Innovation
Introduction
Hiraki Ueda is an esteemed inventor based in Mishima, Japan, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 20 patents, Ueda has established himself as an influential figure in the development of antimicrobial compounds.
Latest Patents
Hiraki Ueda's latest innovations include two notable patents focused on novel compounds with antimicrobial properties. The first patent pertains to intermediates for antimicrobial quinolone carboxylic acids. These comprise 4-oxoquinoline-3-carboxylic acid compounds characterized by various substituents that enhance their efficacy as antimicrobial agents. The second patent revolves around intermediates for antimicrobial benzoheterocyclic compounds, which similarly exhibit excellent antimicrobial activity and utility in pharmaceutical compositions. Both patents underscore Ueda's commitment to advancing medical science through innovative chemical solutions.
Career Highlights
Ueda is currently affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to advance research focused on novel pharmaceutical agents. His extensive experience and dedication have helped propel the company’s capabilities in antimicrobial research, benefiting global health.
Collaborations
Throughout his career, Hiraki Ueda has collaborated with esteemed colleagues, including Hisashi Miyamoto and Kazuyuki Nakagawa. Together, they work on pioneering research that pushes the boundaries of pharmaceutical science, enhancing the efficacy of treatments available to patients.
Conclusion
Hiraki Ueda exemplifies the spirit of innovation, contributing significantly to the field of pharmaceuticals with his extensive patent portfolio. His ongoing work at Otsuka Pharmaceutical Company underscores the importance of collaboration in scientific research. As he continues to develop groundbreaking antimicrobial compounds, Ueda remains a vital asset to the medical community.